dual H1/5-HT2A antagonists (GlaxoSmithKline)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual H1/5-HT2A antagonists (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsHistamine H1 receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A